Taken together, the present study provides a CTD-ILD–focused, noninvasive prediction model that integrates functional (DLCO, respiratory rate), imaging (TLUS), and laboratory (BNP, RBC) measures to capture both parenchymal and vascular involvement. The gene discussed is NPPB; the disease is interstitial lung disease.